All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F17%3A10362057" target="_blank" >RIV/00216208:11150/17:10362057 - isvavai.cz</a>

  • Result on the web

    <a href="http://www.mdpi.com/1422-0067/18/8/1612" target="_blank" >http://www.mdpi.com/1422-0067/18/8/1612</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/ijms18081612" target="_blank" >10.3390/ijms18081612</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril

  • Original language description

    Lactacystin is a proteasome inhibitor that interferes with several factors involved in heart remodelling. The aim of this study was to investigate whether the chronic administration of lactacystin induces hypertension and heart remodelling and whether these changes can be modified by captopril or melatonin. Lactacystin treatment increased systolic blood pressure and induced fibrosis of the left ventricle. NF-κB expression in the LV was increased in all treated groups in the cytoplasm, however, in neither group in the nucleus. Although melatonin had no effect on SBP, only this indolamine (but not captopril) reduced the concentration of insoluble and total collagen in the LV and stimulated the NO-pathway in the lactacystin group. We conclude that chronic administration of lactacystin represents a novel model of hypertension with collagenous rebuilding of the LV, convenient for testing antihypertensive drugs or agents exerting a cardiovascular benefit beyond blood pressure reduction.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    International Journal of Molecular Sciences

  • ISSN

    1422-0067

  • e-ISSN

  • Volume of the periodical

    18

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    15

  • Pages from-to

  • UT code for WoS article

    000408897400015

  • EID of the result in the Scopus database

    2-s2.0-85026388328